the sun malaysia ipaper logo 150x150
Thursday, July 2, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Muhammad Azeem confident Shereen will continue to shine

SURABAYA: National sprint king Muhammad Azeem Mohd Fahmi hopes sprint queen Shereen Samson Vallabouy will not be demoralised for not being selected to fill the wild card slot to compete in the 2024 Paris Olympic Games.

The 20-year-old acknowledged Shereen as a great athlete with opportunities to compete in future Olympic Games, while wishing she continues to shine and uphold the country’s name.

“She always does well, she broke the national (400m) record. For her, I hope this thing (wild card ticket) IS not going to let her down, because I also believe Shereen will do better in the future. She is going to be one of the best runners in Malaysia in the 400 metres.

“Everyone knows that her parents were national former athletes. Even I am looking forward to being like how her family is, the whole family are Olympians. So, I believe in the next edition, she will be in the Olympics as well,“ he told reporters here .

Last Wednesday, Malaysian Athletics Federation (KOM) president Datuk Seri Shahidan Kassim announced that the wild card ticket to the Paris 2024 Olympics was awarded to Muhammad Azeem, thus causing Shereen, who was also in contention for the slot, to miss out.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings